Related Experiment Video
Updated: Feb 23, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.2K
Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients
Manel Ben-Hadj-Mohamed1, Souhir Khelil1, Mokhles Ben Dbibis1
1Biochemistry Laboratory, Farhat Hached Hospital, Sousse, Tunisia.
Iranian Journal of Public Health
|September 13, 2017
Summary
This study in Tunisian rheumatoid arthritis patients found elevated inflammation markers like high-sensitive C-reactive protein and myeloperoxidase. Iron deficiency and reduced albumin were observed, impacting iron metabolism and potentially causing anemia in rheumatoid arthritis.
Area of Science:
- Biochemistry
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease causing joint inflammation and destruction.
- Understanding protein and iron variations in RA patients is crucial for managing inflammation and iron metabolism.
Purpose of the Study:
- To investigate variations in hepatic proteins, myeloperoxidase, and iron levels in Tunisian RA patients.
- To explore the implications of these variations on inflammation and iron metabolism.
Main Methods:
- Serum samples from 172 RA patients and 147 healthy controls were analyzed.
- Assessed levels of high-sensitive C-reactive protein, ceruloplasmin, albumin, transferrin, α-1-acid glycoprotein, haptoglobin, ferritin, myeloperoxidase, and serum iron.
Main Results:
- RA patients showed significantly higher levels of high-sensitive C-reactive protein, α-1-acid glycoprotein, haptoglobin, and myeloperoxidase.
- Albumin and serum iron levels were significantly lower in RA patients compared to controls.
- No significant differences were found in ceruloplasmin, transferrin, or ferritin levels.
Conclusions:
- Elevated acute-phase proteins (CRP, α-1-acid glycoprotein, haptoglobin) indicate active inflammation in RA.
- Pro-inflammatory cytokines in RA disrupt iron metabolism, leading to iron deficiency and anemia.
- These findings highlight the link between inflammation, iron metabolism, and disease severity in rheumatoid arthritis.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
631
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
631
01:20The JAK-STAT Signaling Pathway
13.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.3K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
225
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
737
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
737
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
633
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
633
01:23Rheumatic Heart Disease I: Introduction
605
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
605